Review Article

Manufacturing CAR-NK against tumors: Who is the ideal supplier?
Feifei Guo, Yi Zhang, Jiuwei Cui
Microbiota in colorectal cancer related to liver metastasis
Peijun Wei, Weiming Han, Zitong Zhang, Xue Tian, Chen Yang, Qiaoxuan Wang, Weihao Xie, Ying Liu, Yuanhong Gao, Hui Chang

Original Article

Risk stratification for radioactive iodine refractoriness using molecular alterations in distant metastatic differentiated thyroid cancer
Zhuanzhuan Mu, Xin Zhang, Dongquan Liang, Jugao Fang, Ge Chen, Wenting Guo, Di Sun, Yuqing Sun, Zhentian Kai, Lisha Huang, Jun Liang, Yansong Lin
Plant-based dietary patterns and risk of esophageal cancer: A prospective cohort study spanning 17 years
Xiaorui Zhang, Feifan He, Jiayue Li, Ru Chen, Xinqing Li, Li Li, Fen Liu, Shaoming Wang, Wenqiang Wei
A phase I study of Hemay022, an irreversible dual EGFR/HER2 tyrosine kinase inhibitor in Chinese patients with HER2-positive advanced breast cancer
Pin Zhang, Lin Wang, Yueying Zhen, Zhihong Wang, Hesheng Zhang, Richard Jones, Binghe Xu
Sequential neoadjuvant chemotherapy using pegylated liposomal doxorubicin and cyclophosphamide followed by taxanes with complete trastuzumab and pertuzumab treatment for HER2-positive breast cancer: A phase II single-arm study
Yaping Yang, Liang Jin, Yudong Li, Nanyan Rao, Chang Gong, Shunrong Li, Jiannan Wu, Jinghua Zhao, Linxiaoxiao Ding, Fengxia Gan, Jun Zhang, Ruifa Feng, Zhenzhen Liu, Qiang Liu
Genomic characterization of peritoneal lavage cytology-positive gastric cancer
Zhouqiao Wu, Tingfei Gu, Changxian Xiong, Jinyao Shi, Jingpu Wang, Ting Guo, Xiaofang Xing, Fei Pang, Ning He, Rulin Miao, Fei Shan, Yuan Zhou, Ziyu Li, Jiafu Ji
Clinicopathological significance and immunotherapeutic outcome of claudin 18.2 expression in advanced gastric cancer: A retrospective study
Changsong Qi, Xiaoyi Chong, Ting Zhou, Mingyang Ma, Jifang Gong, Miao Zhang, Jian Li, Jun Xiao, Xiaohui Peng, Zhen Liu, Zonghai Li, Lin Shen, Xiaotian Zhang
Molecular features of gastroenteropancreatic neuroendocrine carcinoma: A comparative analysis with lung neuroendocrine carcinoma and digestive adenocarcinomas
Jianwei Zhang, Hanxiao Chen, Junli Zhang, Sha Wang, Yanfang Guan, Wenguang Gu, Jie Li, Xiaotian Zhang, Jian Li, Xicheng Wang, Zhihao Lu, Jun Zhou, Zhi Peng, Yu Sun, Yang Shao, Lin Shen, Minglei Zhuo, Ming Lu

NHCPRC Guidelines

National Health Commission guidelines for diagnosis and treatment of colorectal cancer 2023 in China (English version)
National Health Commission of the People’s Republic of China; Society of Oncology, Chinese Medical Association
National guidelines for diagnosis and treatment of malignant lymphoma 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of esophageal carcinoma 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of melanoma 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of breast cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of lung cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of gastric cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of cervical cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of prostate cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
National guidelines for diagnosis and treatment of colorectal cancer 2020 in China (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of gastric cancer 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of melanoma 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of malignant lymphoma 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of esophageal carcinoma 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of breast cancer 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of pancreatic cancer 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of cervical cancer 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of primary lung cancer 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of renal cell carcinoma 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of urothelial carcinoma of bladder 2018 (English version)
National Health Commission of the People’s Republic of China
Chinese guidelines for diagnosis and treatment of prostate cancer 2018 (English version)
National Health Commission of the People’s Republic of China

CSCO Guidelines

CSCO guidelines for colorectal cancer version 2023: Updates and insights
Mi Mi, Shanshan Weng, Ziheng Xu, Hanguang Hu, Yi Wang, Ying Yuan
CSCO guidelines for colorectal cancer version 2022: Updates and discussions
Zhijun Yuan, Shanshan Weng, Chenyang Ye, Hanguang Hu, Suzhan Zhang, Ying Yuan
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version)
Jun Zhu, Jun Ma, Union for China Lymphoma Investigators of Chinese Society of Clinical Oncology
Update in version 2021 of CSCO guidelines for colorectal cancer from version 2020
Caixia Dong, Yuwei Ding, Shanshan Weng, Guichao Li, Yanqing Huang, Hanguang Hu, Zhen Zhang, Suzhan Zhang, Ying Yuan
Updates in version 2020 of CSCO guidelines for colorectal cancer from version 2019
Shanshan Weng, Ying Yuan, Xicheng Wang, Gong Chen, Yi Wang, Weiqi Sheng, Xinxiang Li, Aiping Zhou, Zhen Zhang, Guichao Li, Sanjun Cai, Ruihua Xu, Jin Li, Suzhan Zhang
Updates in version 2019 of CSCO guidelines for colorectal cancer from version 2018
Ying Yuan, Xicheng Wang, Gong Chen, Yi Wang, Weiqi Sheng, Xinxiang Li, Aiping Zhou, Zhen Zhang, Guichao Li, Sanjun Cai, Ruihua Xu, Jin Li, Suzhan Zhang
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer 2018 (English version)
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer working group
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer 2018 (English version)
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer working group
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version)
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer working group

Guidelines

Management guidelines for preventing exposure to antineoplastics
Wei Liu, Ziyang Wu, Tong Sun, Shuyao Liang, Jun Zhu, Suodi Zhai, Division of Therapeutic Drug Monitoring of Chinese Pharmacological Society, Hospital Pharmacy Professional Committee of Chinese Pharmaceutical Association, Oncology Society of Chinese Medical Association, Nursing Branch of China International Exchange and Promotive Association for Medical and Healthcare, Division of Drug-induced Diseases of Chinese Pharmacology Society